State Board of Administration of Florida Retirement System’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.5M Sell
89,974
-2,762
-3% -$2.11M 0.13% 135
2025
Q4
$71.6M Sell
92,736
-3,230
-3% -$2.19M 0.13% 130
2025
Q3
$54M Sell
95,966
-8,249
-8% -$4.66M 0.09% 183
2025
Q2
$54.7M Buy
104,215
+1,479
+1% +$825K 0.1% 187
2025
Q1
$65.2M Sell
102,736
-140
-0.1% -$96.3K 0.13% 144
2024
Q4
$73.3M Sell
102,876
-3,884
-4% -$3.26M 0.14% 124
2024
Q3
$112M Sell
106,760
-615
-0.6% -$684K 0.21% 83
2024
Q2
$113M Sell
107,375
-16,749
-13% -$16.2M 0.22% 82
2024
Q1
$102M Buy
124,124
+6,419
+5% +$6.1M 0.24% 86
2023
Q4
$103M Buy
117,705
+5,965
+5% +$4.91M 0.22% 95
2023
Q3
$92M Sell
111,740
-4,100
-4% -$3.22M 0.22% 88
2023
Q2
$83.2M Sell
115,840
-8,284
-7% -$6.39M 0.18% 105
2023
Q1
$102M Sell
124,124
-90
-0.1% -$67.9K 0.24% 86
2022
Q4
$89.6M Sell
124,214
-3,210
-3% -$2.37M 0.22% 97
2022
Q3
$87.8M Buy
127,424
+4,411
+4% +$2.78M 0.23% 85
2022
Q2
$72.7M Buy
123,013
+985
+0.8% +$640K 0.18% 116
2022
Q1
$85.2M Buy
122,028
+333
+0.3% +$211K 0.17% 114
2021
Q4
$76.9M Sell
121,695
-1,732
-1% -$1.06M 0.14% 139
2021
Q3
$74.7M Sell
123,427
-3,503
-3% -$2.17M 0.15% 133
2021
Q2
$70.9M Sell
126,930
-4,050
-3% -$2.05M 0.13% 142
2021
Q1
$62M Sell
130,980
-3,199
-2% -$1.56M 0.12% 152
2020
Q4
$64.8M Sell
134,179
-576
-0.4% -$311K 0.13% 144
2020
Q3
$75.4M Buy
134,755
+2,581
+2% +$1.56M 0.17% 120
2020
Q2
$82.4M Buy
132,174
+20,476
+18% +$11.6M 0.2% 98
2020
Q1
$54.5M Buy
111,698
+4,092
+4% +$1.69M 0.17% 129
2019
Q4
$40.4M Buy
107,606
+182
+0.2% +$61.2K 0.1% 200
2019
Q3
$29.8M Buy
107,424
+1,145
+1% +$339K 0.08% 258
2019
Q2
$33.3M Sell
106,279
-1,110
-1% -$370K 0.09% 231
2019
Q1
$44.1M Buy
107,389
+207
+0.2% +$85.2K 0.12% 181
2018
Q4
$40M Sell
107,182
-164
-0.2% -$60K 0.12% 176
2018
Q3
$43.4M Sell
107,346
-1,902
-2% -$724K 0.11% 189
2018
Q2
$37.7M Buy
109,248
+462
+0.4% +$144K 0.1% 205
2018
Q1
$37.5M Sell
108,786
-1,292
-1% -$449K 0.1% 202
2017
Q4
$41.4M Sell
110,078
-5,247
-5% -$2.13M 0.11% 190
2017
Q3
$51.6M Hold
115,325
0.14% 155
2017
Q2
$56.6M Buy
115,325
+1,087
+1% +$476K 0.16% 134
2017
Q1
$44.3M Sell
114,238
-1,370
-1% -$508K 0.13% 168
2016
Q4
$42.4M Buy
115,608
+73
+0.1% +$27.8K 0.13% 172
2016
Q3
$46.4M Sell
115,535
-1,320
-1% -$530K 0.14% 148
2016
Q2
$40.8M Buy
116,855
+18,984
+19% +$7.31M 0.13% 160
2016
Q1
$35.3M Sell
97,871
-2,410
-2% -$993K 0.13% 154
2015
Q4
$54.4M Sell
100,281
-3,145
-3% -$1.7M 0.2% 99
2015
Q3
$48.1M Sell
103,426
-903
-0.9% -$485K 0.19% 115
2015
Q2
$53.2M Sell
104,329
-1,617
-2% -$789K 0.19% 109
2015
Q1
$47.8M Sell
105,946
-10,808
-9% -$4.58M 0.16% 126
2014
Q4
$47.9M Sell
116,754
-1,488
-1% -$585K 0.15% 138
2014
Q3
$42.6M Sell
118,242
-3,369
-3% -$1.13M 0.14% 149
2014
Q2
$34.4M Sell
121,611
-778
-0.6% -$231K 0.11% 195
2014
Q1
$36.8M Sell
122,389
-13,765
-10% -$4.24M 0.12% 177
2013
Q4
$37.5M Sell
136,154
-2,443
-2% -$703K 0.11% 186
2013
Q3
$43.4M Sell
138,597
-482
-0.3% -$127K 0.14% 144
2013
Q2
$31.3M Buy
+139,079
New +$32.4M 0.1% 203

Other funds holding REGN

State Board of Administration of Florida Retirement System's REGN Position: Q1 2026 in Review

State Board of Administration of Florida Retirement System reduced its Regeneron Pharmaceuticals (REGN) stake by 3% in Q1 2026, selling an estimated $2.11M and leaving 89,974 shares worth $69.5M. The position accounts for 0.13% of the portfolio, ranked #135.

State Board of Administration of Florida Retirement System first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q2 2024. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • State Board of Administration of Florida Retirement System held 89,974 shares of Regeneron Pharmaceuticals worth $69.5M as of Q1 2026.
  • State Board of Administration of Florida Retirement System sold 2,762 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.11M.
  • Regeneron Pharmaceuticals made up 0.13% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #135 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • State Board of Administration of Florida Retirement System's Regeneron Pharmaceuticals position peaked at $113M in Q2 2024.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.